Pulmonary arterial hypertension (PAH) is a progressive, irreversible disease that is frequently delayed in diagnosis and treatment. Watch to learn more about initiating combination therapy in patients with PAH.

More content about PAH is available for AMA PRA Category 1 Credit(s)™
Watch the Webinar ➤ [ Ссылка ]

View the Activity ➤ [ Ссылка ]

Pulmonary Arterial Hypertension Playlist ➤ [ Ссылка ]

This video is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. Developed for physicians and advance practice providers.

свернуть